Huntsworth PLC Trading Update (2932Z)

TIDMHNT

RNS Number : 2932Z

Huntsworth PLC

14 December 2017

Trading update

Huntsworth plc, the healthcare communications and public relations group, today issues a trading update for the 11 months to 30 November 2017.

Trading

The Group continues to trade well and expects to reach at least market consensus* headline profit estimates for the year to 31 December 2017. This has been led by continuing strong growth at Huntsworth Health particularly in Evoke and Apothecom which now account for over 65% of Huntsworth Health revenue and profit. The Creative Engagement Group, which Huntsworth purchased in July 2017, has performed well, is now fully integrated within the Group and is increasingly engaged in joint new business with other Group agencies.

Financial Position

The Group remains in a strong financial position, operating well within its GBP75m facility. Net debt at 30 November 2017 was approximately GBP44m, equating to less than 1.5x net debt to pro forma EBITDA**.

Outlook

The Group is confident about future trading and expects continued good growth prospects in its Healthcare businesses. It remains focused on driving improved operating profit throughout the Group.

*Consensus Headline PBT is GBP22.8m

**Pro forma EBITDA takes into account the full annualisation of M&A in 2017.

 
  Enquiries 
 
 Citigate Dewe Rogerson        020 7638 9571 
 Angharad Couch 
  Nick Reading 
  Elizabeth Kittle 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTGGGWAPUPMGMW

(END) Dow Jones Newswires

December 14, 2017 02:00 ET (07:00 GMT)